Patents Assigned to Fujian Ribio Technology Co., Ltd.
  • Publication number: 20230357811
    Abstract: The present disclosure relates to a synthesis method of ?-nicotinamide mononucleotide (?-NMN) and an intermediate thereof. In the present disclosure, phospholipid metabolism enzymes phospholipase D (PLD) and phospholipase C (PLC) widely present in the biosphere are used as catalysts to prepare ?-NMN through two-step enzymolysis or one-pot synthesis; and an intermediate, namely phosphatidyl nicotinamide riboside (PNR), is obtained during the two-step enzymolysis. The present disclosure has simple reaction steps, low production cost, and environmental friendliness, and is suitable for large-scale industrial production.
    Type: Application
    Filed: June 24, 2020
    Publication date: November 9, 2023
    Applicant: Fujian Ribio Technology Co., Ltd.
    Inventors: Yonghong YUAN, Qi PAN, Xiaoxue GUO, Xusheng ZHAO